MAP Pharmaceuticals, Inc.

• About Us 
  • Message from the CEO
  • Management Team
  • Board of Directors
  • Partnering
  • Contact Us
• Product Pipeline 
  • Migraine
  • Pediatric Asthma
  • Asthma/COPD
  • Diabetes
• Investor Relations 
  • IR Home
  • Press Releases
  • Events and Presentations
  • Corporate Governance
  • Management
  • Board of Directors
  • Committee Composition
  • Annual Reports
  • SEC Filings
  • Stock Information
  • Analyst Coverage
  • Contact Us
• Science & Technology 
• Publications 
  • Migraine
  • Asthma
  • Aerosol Science & Technology

Investor Relations

Print page     Email page

Investor Relations

Recent Releases

Mar 2, 2010
MAP Pharmaceuticals Reports 2009 Fourth Quarter and Year End Financial Results

Feb 23, 2010
MAP Pharmaceuticals to Present at Upcoming Healthcare Conferences

Feb 16, 2010
MAP Pharmaceuticals Announces Initiation of LEVADEX(TM) Pharmacokinetics Trial

View all releases »

Stock Information

NASDAQ:MAPP $16.17	+ 0.67
Mar 10, 2010	3:59 PM ET

Quotes delayed at least 20 minutes.
Information provided by eSignal.